Y-mAbs Therapeutics Inc

(NASDAQ:YMAB)

$5.395

-0.185[-3.32%]

Last update: 3:00PM (Delayed 15-Minutes)
Get Real Time Here

$5.58

0.1850[3.43%]

Open5.610	Close-
Vol / Avg.194.341K / 187.463K	Mkt Cap235.331M
Day Range5.360 - 5.815	52 Wk Range2.700 - 15.860

Y-mAbs Therapeutics Stock (NASDAQ:YMAB) Earnings Dates and Earning Calls

Y-mAbs Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 6

EPS Estimate

$-0.200

Quarterly Revenue Estimate

$20.2M

Annual Revenue (as of Jun 30)

$85M

Earnings History

Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on November 6, 2023. The last reported earnings were for reported on August 10, 2023 for Q2.

What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?

The Actual EPS was $-0.14, which beat the estimate of $-0.24.

What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?

The Actual Revenue was $20.8M, which beat the estimate of $20.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

Y-mAbs Therapeutics Stock (NASDAQ:YMAB) Earnings Dates and Earning Calls

Earnings Date

Nov 6

EPS Estimate

$-0.200

Quarterly Revenue Estimate

$20.2M

Annual Revenue (as of Jun 30)

$85M

Earnings History

Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on November 6, 2023. The last reported earnings were for reported on August 10, 2023 for Q2.

What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?

The Actual EPS was $-0.14, which beat the estimate of $-0.24.

What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?

The Actual Revenue was $20.8M, which beat the estimate of $20.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

Y-mAbs Therapeutics Stock (NASDAQ:YMAB) Earnings Dates and Earning Calls

Earnings Date

Nov 6

EPS Estimate

$-0.200

Quarterly Revenue Estimate

$20.2M

Annual Revenue (as of Jun 30)

$85M

Earnings History

Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on November 6, 2023. The last reported earnings were for reported on August 10, 2023 for Q2.

What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?

The Actual EPS was $-0.14, which beat the estimate of $-0.24.

What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?

The Actual Revenue was $20.8M, which beat the estimate of $20.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

Y-mAbs Therapeutics Stock (NASDAQ:YMAB) Earnings Dates and Earning Calls

Earnings Date

Nov 6

EPS Estimate

$-0.200

Quarterly Revenue Estimate

$20.2M

Annual Revenue (as of Jun 30)

$85M

Earnings History

Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on November 6, 2023. The last reported earnings were for reported on August 10, 2023 for Q2.

What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?

The Actual EPS was $-0.14, which beat the estimate of $-0.24.

What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?

The Actual Revenue was $20.8M, which beat the estimate of $20.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

Y-mAbs Therapeutics Stock (NASDAQ:YMAB) Earnings Dates and Earning Calls

Earnings Date

Nov 6

EPS Estimate

$-0.200

Quarterly Revenue Estimate

$20.2M

Annual Revenue (as of Jun 30)

$85M

Earnings History

Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on November 6, 2023. The last reported earnings were for reported on August 10, 2023 for Q2.

What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?

The Actual EPS was $-0.14, which beat the estimate of $-0.24.

What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?

The Actual Revenue was $20.8M, which beat the estimate of $20.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

Y-mAbs Therapeutics Stock (NASDAQ:YMAB) Earnings Dates and Earning Calls

Earnings Date

Nov 6

EPS Estimate

$-0.200

Quarterly Revenue Estimate

$20.2M

Annual Revenue (as of Jun 30)

$85M

Earnings History

Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on November 6, 2023. The last reported earnings were for reported on August 10, 2023 for Q2.

What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?

The Actual EPS was $-0.14, which beat the estimate of $-0.24.

What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?

The Actual Revenue was $20.8M, which beat the estimate of $20.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

Y-mAbs Therapeutics Stock (NASDAQ:YMAB) Earnings Dates and Earning Calls

Earnings Date

Nov 6

EPS Estimate

$-0.200

Quarterly Revenue Estimate

$20.2M

Annual Revenue (as of Jun 30)

$85M

Earnings History

Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on November 6, 2023. The last reported earnings were for reported on August 10, 2023 for Q2.

What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?

The Actual EPS was $-0.14, which beat the estimate of $-0.24.

What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?

The Actual Revenue was $20.8M, which beat the estimate of $20.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

Y-mAbs Therapeutics Stock (NASDAQ:YMAB) Earnings Dates and Earning Calls

Earnings Date

Nov 6

EPS Estimate

$-0.200

Quarterly Revenue Estimate

$20.2M

Annual Revenue (as of Jun 30)

$85M

Earnings History

Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on November 6, 2023. The last reported earnings were for reported on August 10, 2023 for Q2.

What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?

The Actual EPS was $-0.14, which beat the estimate of $-0.24.

What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?

The Actual Revenue was $20.8M, which beat the estimate of $20.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

Y-mAbs Therapeutics Stock (NASDAQ:YMAB) Earnings Dates and Earning Calls

Earnings Date

Nov 6

EPS Estimate

$-0.200

Quarterly Revenue Estimate

$20.2M

Annual Revenue (as of Jun 30)

$85M

Earnings History

Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on November 6, 2023. The last reported earnings were for reported on August 10, 2023 for Q2.

What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?

The Actual EPS was $-0.14, which beat the estimate of $-0.24.

What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?

The Actual Revenue was $20.8M, which beat the estimate of $20.4M.

Browse earnings estimates, EPS, and revenue on all stocks.